Senator Investment Group LP Elanco Animal Health Inc Transaction History

Senator Investment Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$19.63 - $26.62 $49.1 Million - $66.6 Million	-2,500,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$27.74 - $34.09 $19.4 Million - $23.9 Million	-700,000 Reduced 21.88%	2,500,000 $71 Million
Q3 2021 Nov 12, 2021	BUY	$29.2 - $36.72 $17.5 Million - $22 Million	600,000 Added 23.08%	3,200,000 $102 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $39.9 Million - $49 Million	1,450,000 Added 126.09%	2,600,000 $79.7 Million
Q3 2020 Nov 13, 2020	BUY	$21.1 - $29.13 $24.3 Million - $33.5 Million	1,150,000 New	1,150,000 $32.1 Million

447

478M

3.1M

1.26M

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.51B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.